Toronto Dominion Bank boosted its stake in Monsanto Company (NYSE:MON) by 6.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,014,313 shares of the basic materials company’s stock after purchasing an additional 59,750 shares during the period. Monsanto comprises 0.4% of Toronto Dominion Bank’s investment portfolio, making the stock its 25th largest position. Toronto Dominion Bank owned 0.23% of Monsanto worth $121,519,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently made changes to their positions in the business. Puplava Financial Services Inc. increased its stake in shares of Monsanto by 0.4% during the second quarter. Puplava Financial Services Inc. now owns 2,119 shares of the basic materials company’s stock valued at $251,000 after buying an additional 9 shares during the period. Guardian Life Insurance Co. of America increased its stake in shares of Monsanto by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 1,689 shares of the basic materials company’s stock valued at $191,000 after buying an additional 11 shares during the period. Enterprise Financial Services Corp increased its stake in shares of Monsanto by 1.2% during the second quarter. Enterprise Financial Services Corp now owns 1,384 shares of the basic materials company’s stock valued at $164,000 after buying an additional 16 shares during the period. Forward Management LLC increased its stake in shares of Monsanto by 0.5% during the second quarter. Forward Management LLC now owns 3,201 shares of the basic materials company’s stock valued at $379,000 after buying an additional 16 shares during the period. Finally, Lee Financial Co increased its stake in shares of Monsanto by 0.3% during the second quarter. Lee Financial Co now owns 6,067 shares of the basic materials company’s stock valued at $718,000 after buying an additional 17 shares during the period. 74.50% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This piece was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another site, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The original version of this piece can be read at https://www.thecerbatgem.com/2017/11/13/toronto-dominion-bank-has-121-52-million-holdings-in-monsanto-company-mon.html.

In other Monsanto news, CFO Pierre Courduroux sold 4,320 shares of the business’s stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $122.00, for a total value of $527,040.00. Following the sale, the chief financial officer now directly owns 48,388 shares of the company’s stock, valued at $5,903,336. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Steven Mizell sold 11,526 shares of the business’s stock in a transaction on Monday, October 9th. The stock was sold at an average price of $119.70, for a total value of $1,379,662.20. The disclosure for this sale can be found here. Insiders sold 49,236 shares of company stock worth $5,931,934 over the last three months. Corporate insiders own 0.79% of the company’s stock.

Several equities analysts have recently issued reports on MON shares. Zacks Investment Research cut Monsanto from a “buy” rating to a “hold” rating in a research note on Tuesday, September 12th. Wells Fargo & Company boosted their target price on Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a research note on Tuesday, October 10th. UBS AG cut Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 target price on the stock. in a research note on Friday, August 18th. BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a research note on Saturday, August 19th. Finally, Barclays PLC reissued an “equal weight” rating and set a $124.00 target price (up from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. Eleven analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Monsanto presently has a consensus rating of “Hold” and an average price target of $124.61.

Monsanto Company (MON) traded up $0.96 during trading on Monday, reaching $118.30. The company’s stock had a trading volume of 2,329,700 shares, compared to its average volume of 1,937,834. The company has a quick ratio of 0.83, a current ratio of 1.35 and a debt-to-equity ratio of 1.12. Monsanto Company has a twelve month low of $97.35 and a twelve month high of $122.79. The company has a market capitalization of $52,020.00, a P/E ratio of 21.39, a price-to-earnings-growth ratio of 1.70 and a beta of 1.05.

Monsanto (NYSE:MON) last released its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.41) by $0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The business had revenue of $2.69 billion for the quarter, compared to the consensus estimate of $2.51 billion. During the same period in the previous year, the company posted $0.07 earnings per share. The company’s revenue for the quarter was up 4.8% compared to the same quarter last year. equities analysts expect that Monsanto Company will post 5.74 EPS for the current fiscal year.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.